LncRNA MALAT1 Promotes Diabetic Nephropathy Progression Via MiR-15b-5p/TLR4 Signaling Axis

Overview

Journal J Immunol Res

Publisher Wiley

Specialty Allergy & Immunology

Date 2022 Aug 1

PMID 35910856

Authors

Zijun Yang

Dongxu Song

Yulin Wang

Lin Tang

Affiliations

Soon will be listed here.

Abstract

Objective: The long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) are closely associated with the pathogenesis of diabetic nephropathy (DN). But a complete mechanism for MALAT1 in DN has yet to be identified. This study investigated the effect of MALAT1 on DN through the regulation of miR-15b-5p/TLR4 signaling.

Method: Renal tissues were collected from DN patients. Human renal tubular epithelial cells (HK-2) were used as a model of DN induced by high glucose (HG). We then measured the viability, apoptosis, and inflammatory cytokine levels of HK-2 cells using the corresponding assays. Following transfections of si-MALAT1, si-MALAT1+miR-15b-5p inhibitor, or si-MALAT1+vector TLR4 into HG-stimulated HK-2 cells, cell viability, apoptosis, and inflammatory cytokines were again measured. Furthermore, dual-luciferase reporter assay validated the interactions of MALAT1/miR-15b-5p and miR-15b-5p/TLR4. In addition, the interaction between MALAT1 and miR-15b-5p was investigated by RNA immunoprecipitation (RIP).

Results: A significant upregulation of MALAT1 was observed in DN kidney tissues, as well as in HG-stimulated HK-2 cells. MALAT1 knockdown attenuates the inhibition of cell viability, apoptosis, and inflammatory response induced by HG in HK-2 cells. Moreover, a miR-15b-5p inhibitor or TLR4 overexpression reversed the above effects induced by MALAT1 knockdown.

Conclusion: These results indicate that reduced MALAT1 ameliorates HG-stimulated HK-2 cell damage through an inhibition of the miR-15b-5p/TLR4 axis. MALAT1 may serve as a biomarker and potential therapeutic target for DN.

Citing Articles

Li L, Wu Y, Yang J Int J Mol Sci. 2025; 26(5).

PMID: 40076814 PMC: 11900361. DOI: 10.3390/ijms26052194.

Decoding Kidney Pathophysiology: Omics-Driven Approaches in Precision Medicine.

Delrue C, Speeckaert M J Pers Med. 2024; 14(12).

PMID: 39728069 PMC: 11679258. DOI: 10.3390/jpm14121157.

The lncRNA MALAT1 is upregulated in urine of type 1 diabetes mellitus patients with diabetic kidney disease.

Dieter C, Lemos N, Girardi E, Ramos D, Correa N, Canani L Genet Mol Biol. 2023; 46(2):e20220291.

PMID: 37272835 PMC: 10240573. DOI: 10.1590/1678-4685-GMB-2022-0291.

The regulatory activities of MALAT1 in the development of bone and cartilage diseases.

Zhang D, Xue J, Peng F Front Endocrinol (Lausanne). 2022; 13:1054827.

PMID: 36452326 PMC: 9701821. DOI: 10.3389/fendo.2022.1054827.

The role of lncRNAs in regulation of DKD and diabetes-related cancer.

Cheng Y, Wu X, Xia Y, Liu W, Wang P Front Oncol. 2022; 12:1035487.

PMID: 36313695 PMC: 9606714. DOI: 10.3389/fonc.2022.1035487.

References

Liu Y, Xu Z, Ma F, Jia Y, Wang G . Knockdown of TLR4 attenuates high glucose-induced podocyte injury via the NALP3/ASC/Caspase-1 signaling pathway. Biomed Pharmacother. 2018; 107:1393-1401. DOI: 10.1016/j.biopha.2018.08.134. View

Zhang S, Wang H, Liu Y, Yang W, Liu J, Han Y . Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1/TRPC6 pathway. J Cell Mol Med. 2020; 24(17):9810-9824. PMC: 7520323. DOI: 10.1111/jcmm.15562. View

Zhang H, Yan Y, Hu Q, Zhang X . LncRNA MALAT1/microRNA let-7f/KLF5 axis regulates podocyte injury in diabetic nephropathy. Life Sci. 2020; 266:118794. DOI: 10.1016/j.lfs.2020.118794. View

Zhu L, Wang H, Tang T . Effects of miR-195 on diabetic nephropathy rats through targeting TLR4 and blocking NF-κB pathway. Eur Rev Med Pharmacol Sci. 2021; 25(3):1522-1529. DOI: 10.26355/eurrev_202102_24860. View

Petrillo F, Iervolino A, Zacchia M, Simeoni A, Masella C, Capolongo G . MicroRNAs in Renal Diseases: A Potential Novel Therapeutic Target. Kidney Dis (Basel). 2018; 3(3):111-119. PMC: 5757617. DOI: 10.1159/000481730. View

Wang Y, Liu J, Zhang Q, Wang W, Liu Q, Liu S . Human umbilical cord mesenchymal stem cells attenuate podocyte injury under high glucose via TLR2 and TLR4 signaling. Diabetes Res Clin Pract. 2021; 173:108702. DOI: 10.1016/j.diabres.2021.108702. View

Fu Y, Wang C, Zhang D, Chu X, Zhang Y, Li J . miR-15b-5p ameliorated high glucose-induced podocyte injury through repressing apoptosis, oxidative stress, and inflammatory responses by targeting Sema3A. J Cell Physiol. 2019; 234(11):20869-20878. DOI: 10.1002/jcp.28691. View

Zhu Y, Yang T, Duan J, Mu N, Zhang T . /miR-15b-5p/ mediates endothelial progenitor cells autophagy and affects coronary atherosclerotic heart disease via mTOR signaling pathway. Aging (Albany NY). 2019; 11(4):1089-1109. PMC: 6402525. DOI: 10.18632/aging.101766. View

Liu C, Zhuo H, Ye M, Huang G, Fan M, Huang X . LncRNA MALAT1 promoted high glucose-induced pyroptosis of renal tubular epithelial cell by sponging miR-30c targeting for NLRP3. Kaohsiung J Med Sci. 2020; 36(9):682-691. DOI: 10.1002/kjm2.12226. View

10.

Yuan S, Liu X, Zhu X, Qu Z, Gong Z, Li J . The Role of TLR4 on PGC-1-Mediated Oxidative Stress in Tubular Cell in Diabetic Kidney Disease. Oxid Med Cell Longev. 2018; 2018:6296802. PMC: 5976914. DOI: 10.1155/2018/6296802. View

11.

Hutton H, Ooi J, Holdsworth S, Kitching A . The NLRP3 inflammasome in kidney disease and autoimmunity. Nephrology (Carlton). 2016; 21(9):736-44. DOI: 10.1111/nep.12785. View

12.

Zhang J, Jiang T, Liang X, Shu S, Xiang X, Zhang W . lncRNA MALAT1 mediated high glucose-induced HK-2 cell epithelial-to-mesenchymal transition and injury. J Physiol Biochem. 2019; 75(4):443-452. DOI: 10.1007/s13105-019-00688-2. View

13.

Chen B, Li Y, Liu Y, Xu Z . circLRP6 regulates high glucose-induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells. J Cell Physiol. 2019; 234(11):21249-21259. DOI: 10.1002/jcp.28730. View

14.

Sani H, Hejazian M, Hosseinian Khatibi S, Ardalan M, Zununi Vahed S . Long non-coding RNAs: An essential emerging field in kidney pathogenesis. Biomed Pharmacother. 2018; 99:755-765. DOI: 10.1016/j.biopha.2018.01.122. View

15.

Zhou L, Xu D, Sha W, Shen L, Lu G, Yin X . High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway. J Transl Med. 2015; 13:352. PMC: 4640239. DOI: 10.1186/s12967-015-0710-y. View

16.

Li J, Wang M, Song L, Wang X, Lai W, Jiang S . LncRNA MALAT1 regulates inflammatory cytokine production in lipopolysaccharide-stimulated human gingival fibroblasts through sponging miR-20a and activating TLR4 pathway. J Periodontal Res. 2019; 55(2):182-190. DOI: 10.1111/jre.12700. View

17.

Zhang H, Wei X, Lu S, Lin X, Huang J, Chen L . Protective effect of DMDD, isolated from the root of Averrhoa carambola L., on high glucose induced EMT in HK-2 cells by inhibiting the TLR4-BAMBI-Smad2/3 signaling pathway. Biomed Pharmacother. 2019; 113:108705. DOI: 10.1016/j.biopha.2019.108705. View

18.

Zhuang L, Wang Z, Hu X, Yang Q, Pei X, Jin G . CircHIPK3 Alleviates High Glucose Toxicity to Human Renal Tubular Epithelial HK-2 Cells Through Regulation of miR-326/miR-487a-3p/SIRT1. Diabetes Metab Syndr Obes. 2021; 14:729-740. PMC: 7898210. DOI: 10.2147/DMSO.S289624. View

19.

Natarajan R, Putta S, Kato M . MicroRNAs and diabetic complications. J Cardiovasc Transl Res. 2012; 5(4):413-22. PMC: 3396726. DOI: 10.1007/s12265-012-9368-5. View

20.

Yang M, Luo S, Jiang N, Wang X, Han Y, Zhao H . DsbA-L Ameliorates Renal Injury Through the AMPK/NLRP3 Inflammasome Signaling Pathway in Diabetic Nephropathy. Front Physiol. 2021; 12:659751. PMC: 8120163. DOI: 10.3389/fphys.2021.659751. View